Keyphrases
Antiretroviral Therapy
100%
Medicaid
100%
New Antiretrovirals
100%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
100%
African American
42%
AIDS/HIV
28%
Treatment Initiation
28%
Medicaid Waiver
28%
Waiver Program
28%
Logistic Regression
14%
Bivariate Analysis
14%
White People
14%
Hispanic
14%
New Jersey
14%
Non-associated
14%
Race-ethnicity
14%
Regression Analysis
14%
Pharmacy
14%
Older Individuals
14%
Protease Inhibitors
14%
Hispanic Ethnicity
14%
Patient Characteristics
14%
Health Care Services
14%
Injection Drug Users
14%
Injection Drug Use
14%
Follow-up Time
14%
Inappropriate Use
14%
Survival Analysis
14%
Ordinary Least Squares Regression
14%
Surveillance Data
14%
Proportional Hazards Model
14%
Inhibitor Therapy
14%
Medicaid Beneficiaries
14%
Bivariate
14%
Highly Active Antiretroviral Therapy (HAART)
14%
Drug Use History
14%
Financial Barriers
14%
Treatment Analysis
14%
Supporting Patients
14%
Sociodemographic Subgroups
14%
Mathematics
Bivariate
100%
Logistic Regression
50%
Proportional Hazards Model
50%
Least Square
50%
Main Result
50%
Survival Analysis
50%
Analysis Technique
50%
Drug User
50%
Proportional Hazard Regression
50%
Square Regression
50%
Medicine and Dentistry
Nonnucleoside Reverse Transcriptase Inhibitor
100%
HIV/AIDS
28%
Case Management
28%
Population Research
14%
Logistic Regression Analysis
14%
Proportional Hazards Model
14%
Least Square Analysis
14%
Patient Characteristics
14%
Proteinase Inhibitor
14%
Drug Use
14%
Drug Administration
14%
Health Service
14%
Bivariate Analysis
14%
Survival Analysis
14%
Highly Active Antiretroviral Therapy
14%
Nursing and Health Professions
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Human Immunodeficiency Virus
28%
Drug Use
28%
Case Management
28%
Logistic Regression Analysis
14%
Proportional Hazards Model
14%
Health Service
14%
Bivariate Analysis
14%
Least Square Analysis
14%
Health Maintenance Organization
14%
Proteinase Inhibitor
14%
Survival Analysis
14%
Highly Active Antiretroviral Therapy
14%
Agricultural and Biological Sciences
Reverse-Transcriptase Inhibitor
100%
African
42%
Americans
42%
Human Immunodeficiency Virus
28%
Drug Injection
28%
Jersey
14%
Least Square
14%
Protease
14%
Psychology
Medicaid
100%
Proportional Hazards Regression Model
14%
Main Result
14%
Regression Analysis
14%
Survival Analysis
14%